{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:01:46Z","timestamp":1785250906173,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016109","name":"Taishan Industry Leading Talents","doi-asserted-by":"publisher","award":["tscy20170519"],"award-info":[{"award-number":["tscy20170519"]}],"id":[{"id":"10.13039\/501100016109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vaccine.2026.128754","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T03:09:52Z","timestamp":1779851392000},"page":"128754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel ferritin-based nanoparticle vaccine targeting lgE confers protection against chronic allergic asthma in a murine model"],"prefix":"10.1016","volume":"86","author":[{"given":"Wenjie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiantong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128754_bb0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s13148-011-0028-4","article-title":"The role of epigenetic dysregulation in the epidemic of allergic disease","volume":"2","author":"Prescott","year":"2020","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.vaccine.2026.128754_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.18773\/austprescr.2024.015","article-title":"Biologic therapies for severe asthma with persistent type 2 inflammation","volume":"47","author":"Chandrasekara","year":"2024","journal-title":"Aust Prescr"},{"key":"10.1016\/j.vaccine.2026.128754_bb0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri3632","article-title":"The production and regulation of IgE by the immune system","volume":"14","author":"Wu","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128754_bb0020","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1067\/mai.2001.116436","article-title":"Molecular and cellular mechanisms of allergic disease","volume":"108","author":"Broide","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2026.128754_bb0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4161\/hv.5.5.7442","article-title":"Vaccines targeting IgE in the treatment of asthma and allergy","volume":"5","author":"Peng","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2026.128754_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1069100","article-title":"IgE glycans promote anti-IgE IgG autoantibodies that facilitate IgE serum clearance via Fc receptors","volume":"13","author":"Plattner","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128754_bb0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/iid3.98","article-title":"Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates","volume":"4","author":"Weeratna","year":"2016","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.vaccine.2026.128754_bb0040","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1398-9995.2004.00533.x","article-title":"Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma","volume":"59","author":"Ayres","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.vaccine.2026.128754_bb0045","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1111\/all.16090","article-title":"Generation of a virus-like particles based vaccine against IgE","volume":"79","author":"Gharailoo","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.vaccine.2026.128754_bb0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1586\/14760584.7.2.193","article-title":"Therapeutic vaccines against IgE-mediated allergies","volume":"7","author":"Hellman","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.128754_bb0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design","volume":"6","author":"Purcell","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2026.128754_bb0060","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128754_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1515\/mr-2023-0001","article-title":"Ferritin-based nanomedicine for disease treatment","volume":"3","author":"Zhu","year":"2023","journal-title":"Med Rev"},{"key":"10.1016\/j.vaccine.2026.128754_bb0070","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3390\/pharmaceutics13101621","article-title":"Functionalizing ferritin nanoparticles for vaccine development","volume":"13","author":"Rodrigues","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2026.128754_bb0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/acscentsci.0c01405","article-title":"A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice","volume":"7","author":"Powell","year":"2021","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.vaccine.2026.128754_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1361323","article-title":"A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza A (H1N1) virus elicits protective immune responses in mice and pigs","volume":"15","author":"Tang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128754_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11040821","article-title":"A ferritin nanoparticle-based Zika virus vaccine candidate induces robust humoral and cellular immune responses and protects mice from lethal virus challenge","volume":"11","author":"Pattnaik","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128754_bb0090","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational Design of an Epstein-Barr Virus Vaccine Targeting the receptor-binding site","volume":"162","author":"Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2026.128754_bb0095","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.vaccine.2012.01.005","article-title":"Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice","volume":"30","author":"Ma","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128754_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10112874","article-title":"Therapeutical targets in allergic inflammation","volume":"10","author":"Salvati","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.vaccine.2026.128754_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110495","article-title":"Aiming to IgE: drug development in allergic diseases","volume":"121","author":"Ling","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2026.128754_bb0110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2026.128754_bb0115","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.rmed.2013.04.017","article-title":"The eXpeRience registry: the \u2018real-world\u2019 effectiveness of omalizumab in allergic asthma","volume":"107","author":"Braunstahl","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.vaccine.2026.128754_bb0120","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jaci.2003.10.003","article-title":"Omalizumab treatment downregulates dendritic cell FcepsilonRI expression","volume":"112","author":"Prussin","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2026.128754_bb0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaci.2004.06.032","article-title":"Omalizumab-induced reductions in mast cell Fce psilon RI expression and function","volume":"114","author":"Beck","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2026.128754_bb0130","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2026.128754_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/1476-7961-8-3","article-title":"Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective","volume":"8","author":"Pate","year":"2010","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.vaccine.2026.128754_bb0140","doi-asserted-by":"crossref","first-page":"16808","DOI":"10.1074\/jbc.M500965200","article-title":"Disulfide linkage controls the affinity and stoichiometry of IgE Fcepsilon3-4 binding to FcepsilonRI","volume":"280","author":"Hunt","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2026.128754_bb0145","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0264-410X(02)00732-6","article-title":"Synthetic IgE peptide vaccine for immunotherapy of allergy","volume":"21","author":"Wang","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128754_bb0150","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1365-2222.2007.02741.x","article-title":"Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents","volume":"37","author":"Peng","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.vaccine.2026.128754_bb0155","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/vaccines10091447","article-title":"Self-assembling protein nanoparticles in the Design of Vaccines: 2022 update","volume":"10","author":"Morales-Hern\u00e1ndez","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128754_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00404","article-title":"Interactions between nanoparticles and dendritic cells: from the perspective of cancer immunotherapy","volume":"8","author":"Jia","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.vaccine.2026.128754_bb0165","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128754_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2020.01.007","article-title":"Shaping humoral immunity to vaccines through antigen-displaying nanoparticles","volume":"65","author":"Irvine","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2026.128754_bb0175","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Rold\u00e3o","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.128754_bb0180","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1152\/physrev.1978.58.2.317","article-title":"Ferritin: structure, biosynthesis, and role in iron metabolism","volume":"58","author":"Munro","year":"1978","journal-title":"Physiol Rev"},{"key":"10.1016\/j.vaccine.2026.128754_bb0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0005-2728(96)00022-9","article-title":"The ferritins: molecular properties, iron storage function and cellular regulation","volume":"1275","author":"Harrison","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2026.128754_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2018.02.042","article-title":"Ferritin-based drug delivery systems: hybrid nanocarriers for vascular immunotargeting","volume":"282","author":"Khoshnejad","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2026.128754_bb0195","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.drudis.2020.03.006","article-title":"Epitope-based vaccine design: a comprehensive overview of bioinformatics approaches","volume":"25","author":"Parvizpour","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2026.128754_bb0200","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/all.16530","article-title":"Vaccine-induced anti-IgE antibodies neutralize free IgE but fail to bind and activate mast cell-displayed IgE","volume":"80","author":"Gharailoo","year":"2026","journal-title":"Allergy"},{"key":"10.1016\/j.vaccine.2026.128754_bb0205","doi-asserted-by":"crossref","DOI":"10.1111\/all.70287","article-title":"A case for Anti-IgE vaccination","author":"Engeroff","year":"2026","journal-title":"Allergy"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:38:52Z","timestamp":1785249532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":41,"alternative-id":["S0264410X26005633"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128754","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel ferritin-based nanoparticle vaccine targeting lgE confers protection against chronic allergic asthma in a murine model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128754"}}